GregK
Moderator emeritus
- Joined
- Jan 29, 2013
- Messages
- 3,295
- Reason
- PALS
- Diagnosis
- 11/2012
- Country
- US
- State
- CO
- City
- Colorado Springs
The U.S. Food and Drug Administration (FDA) has given Fast Track designation to VM BioPharma’s lead investigational drug candidate, VM202, a potential gene therapy for the treatment of amyotrophic lateral sclerosis (ALS).
Link here: https://alsnewstoday.com/2016/05/18...ients-with-amyotrophic-lateral-sclerosis-als/
Link here: https://alsnewstoday.com/2016/05/18...ients-with-amyotrophic-lateral-sclerosis-als/